187 related articles for article (PubMed ID: 31050820)
1. Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
Bornschein J; Wernisch L; Secrier M; Miremadi A; Perner J; MacRae S; O'Donovan M; Newton R; Menon S; Bower L; Eldridge MD; Devonshire G; Cheah C; Turkington R; Hardwick RH; Selgrad M; Venerito M; Malfertheiner P; ; Fitzgerald RC
Int J Cancer; 2019 Dec; 145(12):3389-3401. PubMed ID: 31050820
[TBL] [Abstract][Full Text] [Related]
2. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
Geng Q; Lao J; Zuo X; Chen S; Bei JX; Xu D
J Pathol; 2020 Nov; 252(3):263-273. PubMed ID: 32715475
[TBL] [Abstract][Full Text] [Related]
3. Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
Yoon JY; Brezden-Masley C; Streutker CJ
BMC Cancer; 2020 Sep; 20(1):860. PubMed ID: 32894084
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic subgroups of esophageal and gastric adenocarcinoma with differential GATA5 DNA methylation associated with clinical and lifestyle factors.
Wang X; Kang GH; Campan M; Weisenberger DJ; Long TI; Cozen W; Bernstein L; Wu AH; Siegmund KD; Shibata D; Laird PW
PLoS One; 2011; 6(10):e25985. PubMed ID: 22028801
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal junction and gastroesophageal junction carcinoma : a short update.
Ekmektzoglou KA; Apostolopoulos P; Samelis G; Alexandrakis G
Acta Gastroenterol Belg; 2016; 79(4):471-479. PubMed ID: 28209106
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.
Li Z; Zou X; Xie L; Dong H; Chen Y; Liu Q; Wu X; Zhou D; Tan D; Zhang H
PLoS One; 2013; 8(11):e80665. PubMed ID: 24236193
[TBL] [Abstract][Full Text] [Related]
7. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.
van Duin M; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Siersema PD; van Dekken H
Cytogenet Genome Res; 2007; 118(2-4):130-7. PubMed ID: 18000363
[TBL] [Abstract][Full Text] [Related]
8.
Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
[TBL] [Abstract][Full Text] [Related]
9. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
10. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
[TBL] [Abstract][Full Text] [Related]
11. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.
Tanner M; Hollmén M; Junttila TT; Kapanen AI; Tommola S; Soini Y; Helin H; Salo J; Joensuu H; Sihvo E; Elenius K; Isola J
Ann Oncol; 2005 Feb; 16(2):273-8. PubMed ID: 15668283
[TBL] [Abstract][Full Text] [Related]
12. Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.
van Dekken H; Tilanus HW; Hop WC; Dinjens WN; Wink JC; Vissers KJ; van Marion R
Cancer Genet Cytogenet; 2009 Feb; 189(1):37-42. PubMed ID: 19167610
[TBL] [Abstract][Full Text] [Related]
13. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
15. Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.
Weinberg BA; Xiu J; Hwang JJ; Shields AF; Salem ME; Marshall JL
Oncologist; 2018 Oct; 23(10):1171-1177. PubMed ID: 29703766
[TBL] [Abstract][Full Text] [Related]
16. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.
Driessen A; Nafteux P; Lerut T; Van Raemdonck D; De Leyn P; Filez L; Penninckx F; Geboes K; Ectors N
Mod Pathol; 2004 Jan; 17(1):49-55. PubMed ID: 14631371
[TBL] [Abstract][Full Text] [Related]
17. Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Alvarez-Manceñido F; Jimenez-Fonseca P; Carmona-Bayonas A; Arrazubi V; Hernandez R; Cano JM; Custodio A; Pericay Pijaume C; Aguado G; Martínez Lago N; Sánchez Cánovas M; Cacho Lavin D; Visa L; Martinez-Torron A; Arias-Martinez A; López F; Limón ML; Vidal Tocino R; Fernández Montes A; Alsina M; Pimentel P; Reguera P; Martín Carnicero A; Ramchandani A; Granja M; Azkarate A; Martín Richard M; Serra O; Hernández Pérez C; Hurtado A; Gil-Negrete A; Sauri T; Morales Del Burgo P; Gallego J
Gastric Cancer; 2021 Jul; 24(4):926-936. PubMed ID: 33651195
[TBL] [Abstract][Full Text] [Related]
18. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.
Demicco EG; Farris AB; Baba Y; Agbor-Etang B; Bergethon K; Mandal R; Daives D; Fukuoka J; Shimizu M; Dias-Santagata D; Ogino S; Iafrate AJ; Gaissert HA; Mino-Kenudson M
Mod Pathol; 2011 Sep; 24(9):1177-90. PubMed ID: 21572404
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.
Suh YS; Na D; Lee JS; Chae J; Kim E; Jang G; Lee J; Min J; Ock CY; Kong SH; George J; Zhang C; Lee HJ; Kim JI; Kim SJ; Kim WH; Lee C; Yang HK
Ann Surg; 2022 Apr; 275(4):706-717. PubMed ID: 33086305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
